Immunohistochemical expression of Heat Shock Protein 27, in normal hyperplastic and neoplastic endometrium: Correlation with estrogen and progesterone receptor status, p53, pRb and proliferation associated indices (PCNA, MIB 1)

Heat shock protein 27 (HSP27) is a relatively small protein produced in response to pathophysiological stress. In the current prospective study the presence and localization of HSP27 was associated with other potential prognostic factors such as: estrogen and progesterone receptors, p53 and proliferative associated indices (MIB1, PCNA). One hundred and twenty-two samples of endometrial tissues (65 endometrial carcinomas, 28 adenomatous hyperplasias, 31 normal endometrium) were studied. Patient records were examined for FIGO stage, grade, and depth of myometrial invasion, histology and lympho-vascular space invasion. HSPp27 expression was lower in the group of carcinomas when compared with the cases of adenomatous hyperplasias (p < 0.0001), normal proliferative (p < 0.0001) and secretory endometrium (p = 0.02). HSP27 expression was higher in carcinomas from premenopausal women in comparison with women in menopausal status and postmenopausal status. Multivariate tests showed no statistical significance of HSP27 expression according to tumor grade and stage. A positive relationship between the expression of HSP27 expression and estrogen receptors (p = 0.0018) as well as with progesterone receptor (p = 0.0012) was found with linear regression analysis of variance. Our data showed that the lower HSP27 expression in endometrial carcinomas in comparison with hyperplastic and normal endometrium may indicate a decreased endogenous protection mechanism against the various stressful stimuli. This expression could be under hormonal control and does not seem to be correlated with other conventional or possible prognostic parameters.

HSP27; ER; PR; p53; MIB I; PCNA; Endometrial carcmoma

[1] Ciocca D.R., Oesterreich S., Chamnss G.C., McGuire W.L., Fuqua S.A.: "Biological and clinical implications of heat shock protein 27000 (HSP27): a review". J. Nat. Cancer Institute, 1993, 85, 1558.

[2] Mahvi D.M., Carper S.W., Storm F.K.: "Over-expression of 27- kDa-heat shock protein in MCF-breast cancer cells: Effects on lymphocyte killing by natural killer and gamma delta T cells". Cancer Immunol. Immunother., 1993, 37, 181.

[3] Ciocca D.R., Adams D.J., Edwards D.P., Bjercke R.J., McGuire W.L.: "Distribution of an estrogen-induced protein with a molecuJar weight of 24,000 in normal and malignant tissues and cells". Cancer Res., 1983, 31, 1204.

[4] Adams DJ., McGuire W.L.: "Quantitative enzyme-linked immunoassorbent assay for the estrogen related Mr 24,000 protein in human breast tumors: Correlation with estrogen and progesterone receptors". Cancer Res., 1985, 45, 2445.

[5] Ciocca D.R., Suzann AW. Fuqua, Sarah Lock-Lim, David 0. Toft, William J. Welch, William L. McGuire: "Response of human breast cancer cells to heat shock and chemotherapeutic drugs". Cancer Res., 1992, 52, 3648.

[6] Oesterreich S., Weng C.N., Qiu M., Hilsenbeck S., Osborne C.K., Suzann A. W., Fuqua AW.: "The small heat shock protein HSP27 is correlated with growth and drug resistance in human breast cancer cell lines". Cancer Res., 1993, 53, 4443.

[7] Kamishima T., Fukuda T., Yoshiya N., Suzuki T.: "Expression and intracellular localization of heat shock proteins in multidrug resistance of a cisplatin resistant human ovarian cancer cell line". Cancer Lett., 1997, 116, 205.

[8] Geisler J.P., Hans E., Geisler H.E., Tammela J., Wiemann M.C., Zhou Z. et al.: "Heat shock protein 27: An independent prognostic indicator of survival in patients with epithelial ovarian carcinoma". Gynecol. Oneal., 1998, 69, 14.

[9] Park C.S., Joo I.S., Song S.Y., Kim D.S., Bae D.S., Lee J.H.: "An Immunohistochemical analysis of heat shock protein 70, p53 and estrogen receptor status in carcinoma of the uterine cervix". Gynecol. Oneal., 1999, 74, 53.

[10] Geisler J.P., Geisler H.E., Tammela J., Wiemann M.C., Zhou Z., Miller G.A., Crabtree W.: "Heat shock protein 27: An independent prognostic indicator of survival in patients with epithelial ovarian carcinoma". Gynecol. Oneal., 1998, 69, 14.

[11] Nakapoulou K., Lazaris A.C., Baltas D., Giannopoulou I., Kavanzaw N., Tsonou A.: "Prognostic evaluation of estrogen regulated protein immunoreactivity in ductal invasive (NOS) breast cancer". Virchows Arch., 1995, 427, 33.

[12] Storm F.K., Mahvi D.M., Gilchrist K.W.: "Lack of association between tumor necrosis and HSP27 expression in primary breast cancer". J. Surg. Oneal., 1996, 61, 14.

[13] Seymour L., Bezwoda W.R., Meyer K.: "Tumor factors predicting for prognosis in metastatic breast cancer". Cancer, 1990, 66, 2390.

[14] Tetu B., Brisson J., Landry J., Huot J.: "Prognostic significance of heat shock protein-27 in node positive breast carcinoma: An immunohistochemical study". Breast Cancer Res. Treat., 1995, 36, 93.

[15] Tetu B., Lacasse B., Boucard H.L., Lagace R., Huot J., Landry J.: "Prognostic influence of HSP-27 in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study". Cancer Res., 1992, 52, 2325.

[16] Kawanishi K., Shiozaki H., Doki Y., Sakita I., Inoue M., Yano M. et al.: "Prognostic significance of heat shock protein 27 and 70 in patients with squamous cell carcinoma of esophagus". Cancer, 1999, 85, 1649.

[17] Harisson J.D., Jones J.A., Ellis I.O., Morris D.L.: "Oestrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer". Br. J. Surg., 1991, 78, 334.

[18] Storm F.K.. Mahvi D.M., Gilchrist K.W.: "HSP-27 has no diagnostic or prognostic significance in prostate or bladder cancer". Urology, 1993, 42, 379.

[19] Devaja 0., King R.J., Papadopoulos A., Raju K.S.: "Heat-shock protein 27 and its role in female reproductive organs". Eur. J Gynaecol. Oncol., 1997, 18, 16.

[20] Ciocca D.R., Puy L.A., Fasoli L.C.: "Studies of estrogen receptor, progesterone receptor, and estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix". Cancer Res., 1989, 4, 4298.

[21] Ciocca D.R., Stati A.O., Amprino de Castro M.M.: "Colocalization of estrogen and progesterone receptors with an estrogen regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue". Breast Cancer Res. Treat., 1990, 16, 243.

[22] McGuire W.L., Dressler L.G., Sledge G.W., Ramzy I., Ciocca D.R.: "An estrogen-regulated protein in normal and malignant endometrium". J. Steroid. Biochem., 1986, 24, 155.

[23] Geisler J.P., Geisler H.F., Tammela J., Miller G.A., Wiemann M.C., Zhou Z.: "A study of heat shock protein 27 in endometrial carcinoma". Gynecol. Oncol., 1999, 72, 347.

[24] Raju K.S., King R.J., Kaern J., Sumner D., Abeler V.M., Mandalaya S., Trope C.: "Influence of HSP27 and steroid receptor status on provera sensitivity, DNA-ploidy and survival of females with endometrial cancer". Int. J. Gynecol. Cancer, 1995, 5, 94.

[25] Wataba K., Saito T., Fukunaka K., Ashihara K., Nishimura M., Kudo R.: "Over-expression of heat shock proteins in carcinogenic endometrium". Int. J. Cancer, 2001, 91, 448.

[26] FIGO stages-1988 revision. Gynecol. Oncol., 1989, 35, 125.

[27] Segreti E.M., Novotny D.B., Soper J. T., Mutch D.G., Creasman W.T., McCarty K.S.: "Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone and estrogen receptor". Obstet. Gynecol., 1989, 73, 780.

[28] Sung C.J., Zheng Y., Quddus M.R., Kang X., Zhang Z.F., LauchIan S.C., Zheng W.: "p53 as a significant prognostic marker in endometrial carcinoma". Int. J. Gynecol. Cancer, 2000, 10, 119.

[29] Lindquist S., Craig E.A.: "The heat shock proteins". Ann. Rev. Genet., 1988, 22, 631.

[30] Edwards D.P., Adams D.J., Savage N., McGuire W.L.: "Estrogen induced synthesis of specific proteins in human breast cancer cells". Biochem. Biophys. Res. Commun., 1980, 93, 804.

[31] Masiakowski P., Breathnach R., Bloch J., Gannon F., Krust A., Chambon P.: "Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line". Nucleic Acids Res., 1982, 10, 7895.

[32] Khalid H., Tsutsumi K., Yamashita H., Kishikawa M., Yasunaga A., Shibata S.: "Expression of the small heat shock protein (HSP) 27 in human astrocytomas correlates with histologic grades and tumour growth fractions". Cell. Mal. Neurobiol., 1995, 15, 257.

[33] Fortin A., Raybaud-Diogene H., Tetu B., Deschenes R., Huot J., Landry J.: "Overexpression of the 27 KDa heat shock protein is associated with thermoresistance and chemoresistance but not with radioresistance". Int. J. Radiat. Oneal. Biol. Phys., 2000, 46, 1259.

[34] Malusecka E., Zborek A., Krzyzowska-Gruca S., Krawczyk Z.； "Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study". Anticancer Res., 2001, 21, 1015.

[35] Vargas-Roig L.M., Fanelli M.A., Lopez L.A., Gago E.E., Tello O., Aznar J.C., Ciocca D.R.: "Heat shock proteins and cell proliferation in human breast cancer biopsy samples". Cancer Detect. Prev., 1997, 21, 441.